Bank of Montreal
BPMC

Bank of Montreal’s Blueprint Medicines BPMC Stock Holding History

Bank of Montreal’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-68,562
Closed -$6.35M – 3549
2024
Q3 		$6.35M Sell
68,562
-478
-0.7% -$47.5K ﹤0.01% 1218
2024
Q2 		$7.46M Buy
+69,040
New +$6.91M ﹤0.01% 1123
2023
Q3 		– Sell
-6,605
Closed -$419K – 3823
2023
Q2 		$419K Buy
+6,605
New +$359K ﹤0.01% 2709
2022
Q1 		– Sell
-22,008
Closed -$2.44M – 4149
2021
Q4 		$2.44M Buy
+22,008
New +$2.3M ﹤0.01% 1506
2021
Q2 		– Sell
-2,935
Closed -$275K – 3806
2021
Q1 		$275K Sell
2,935
-6,224
-68% -$621K ﹤0.01% 2972
2020
Q4 		$980K Buy
9,159
+5,984
+188% +$631K ﹤0.01% 2257
2020
Q3 		$307K Sell
3,175
-1,766
-36% -$136K ﹤0.01% 2539
2020
Q2 		$388K Buy
4,941
+4,551
+1,167% +$308K ﹤0.01% 2394
2020
Q1 		$24K Sell
390
-6,762
-95% -$435K ﹤0.01% 3171
2019
Q4 		$573K Sell
7,152
-16,539
-70% -$1.24M ﹤0.01% 2590
2019
Q3 		$1.74M Buy
23,691
+3,694
+18% +$319K ﹤0.01% 1775
2019
Q2 		$1.89M Buy
19,997
+2,722
+16% +$225K ﹤0.01% 1727
2019
Q1 		$1.38M Buy
17,275
+15,441
+842% +$1.14M ﹤0.01% 1878
2018
Q4 		$99K Sell
1,834
-588
-24% -$35.7K ﹤0.01% 2950
2018
Q3 		$189K Sell
2,422
-10
-0.4% -$695 ﹤0.01% 2784
2018
Q2 		$154K Buy
2,432
+748
+44% +$59.5K ﹤0.01% 2897
2018
Q1 		$154K Sell
1,684
-4,744
-74% -$409K ﹤0.01% 2748
2017
Q4 		$484K Buy
6,428
+6,200
+2,719% +$436K ﹤0.01% 2297
2017
Q3 		$16K Hold
228
– – ﹤0.01% 3578
2017
Q2 		$12K Hold
228
– – ﹤0.01% 3673
2017
Q1 		$9K Hold
228
– – ﹤0.01% 3577
2016
Q4 		$7K Buy
+228
New +$6.87K ﹤0.01% 3670

Other funds holding BPMC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bank of Montreal's BPMC Position: Q4 2024 in Review

Bank of Montreal sold out of Blueprint Medicines (BPMC) in Q4 2024, closing a stake of 68,562 shares — an estimated $6.35M sold.

Bank of Montreal first reported a position in BPMC in Q4 2016 and held it in 22 quarters. The position peaked at $7.46M in Q2 2024. 345 funds tracked by Wall St. Rank hold BPMC as of Q4 2024.

  • Bank of Montreal reported no remaining Blueprint Medicines position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 68,562 Blueprint Medicines shares in Q4 2024, an estimated $6.35M.
  • Bank of Montreal first reported a position in Blueprint Medicines in Q4 2016 and held it in 22 quarters.
  • Bank of Montreal's Blueprint Medicines position peaked at $7.46M in Q2 2024.
  • 345 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.